PMV portfolio
PMV has 11 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It led 4 of the 16 rounds it joined. Its most recent investment on record is Logibot's $1.61M Seed round in September 2026, alongside BAN Flanders, RDY Ventures and Beam. By category, its portfolio leans toward Health and bio (7) and Robotics and hardware (3). It has co-invested with V-Bio Ventures, VIB and Qbic Fund, most often V-Bio Ventures (7 rounds).
What PMV invests in
- Health and bio · 7 · 64%
- Robotics and hardware · 3 · 27%
- Developer tools and cloud · 3 · 27%
- Manufacturing and industrial · 2 · 18%
- Logistics and mobility · 1 · 9%
- AI agents · 1 · 9%
- Voice and audio AI · 1 · 9%
- Education · 1 · 9%
PMV recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Seed · $1.61M | BAN Flanders, RDY Ventures, Beam (lead) | ||
| Series A · $9.27M | Angelwise, Keen Venture Partners (lead), Capricorn Partners +1 | ||
| Series A · $11.73M · lead | KU Leuven, HERAN Partners, Gemma Frisius Fund +1 | ||
| Series B+ · $11.81M · lead | Qbic Fund (lead), Seventure Partners, Anacura +3 | ||
| Series A · $85M | Asabys Partners, CMT Research Foundation, Newton Biocapital +6 | ||
| Series B+ · $37M | Angelini Ventures (lead), EQT Health Economics, 15th Rock +5 | ||
| Series A · $7.5M | Airbridge Equity Partners (lead) | ||
| Series B+ · $65M | MINTS, Fund+, Wellington Management +7 |
How PMV invests
PMV portfolio companies
LLogibot$1.61MSeed · Sep 2026
AAzumuta$9.27MSeries A · Nov 2025
AAspect Analytics$11.73MSeries A · Sep 2025
AAnimab$11.81MSeries B+ · Jul 2025
AAugustine Therapeutics$85MSeries A · Mar 2025
NNobi$37MSeries B+ · Feb 2025
AApideck$7.5MSeries A · Dec 2024
CConfo Therapeutics$65MSeries B+ · Aug 2024
EeTheRNA Immunotherapies$39MSeries B+ · Aug 2022
SSpectaCellbacker
NNXGSATbacker
| Company | Round with PMV | Total raised | Latest raise |
|---|---|---|---|
Robotics and hardware |
Seed · $1.61M | $1.61M | Sep 17, 2026 Seed |
AI agents |
Series A · $9.27M | $12.22M | Nov 13, 2025 Series A |
Voice and audio AI |
Series A · $11.73M · lead | $11.73M | Sep 9, 2025 Series A |
Health and bio |
Series B+ · $11.81M · lead | $22.08M | Jul 1, 2025 Series B+ |
Health and bio |
Series A · $85M | $103.17M | Mar 24, 2025 Series A |
Health and bio |
Series B+ · $37M | $41M | Feb 4, 2025 Series B+ |
Fintech |
Series A · $7.5M | $7.5M | Dec 14, 2024 Series A |
Health and bio |
Series B+ · $65M | $99M | Aug 5, 2024 Series B+ |
Health and bio |
Series B+ · $39M | $104.41M | Aug 24, 2022 Series B+ |
Health and bio |
backer | $6.72M | Oct 11, 2026 Seed |
Robotics and hardware |
backer | undisclosed | Oct 21, 2025 Seed |
Most frequent co-investors
VV-Bio Ventures7 shared rounds · last Jul 1, 2025
VVIB7 shared rounds · last Jul 1, 2025
QQbic Fund4 shared rounds · last Jul 1, 2025
FFund+4 shared rounds · last Aug 5, 2024
CCapricorn Partners3 shared rounds · last Nov 13, 2025
GGemma Frisius Fund3 shared rounds · last Sep 9, 2025
SSeventure Partners3 shared rounds · last Jul 1, 2025
AAgri Investment Fund3 shared rounds · last Jul 1, 2025
OOmega Funds3 shared rounds · last Aug 24, 2022
AAngelwise2 shared rounds · last Nov 13, 2025
AAsabys Partners2 shared rounds · last Mar 24, 2025
CCMT Research Foundation2 shared rounds · last Mar 24, 2025
Similar investors
DDecheng Capital11 companies · 6 deals in 12 mo
LLightbank11 companies · 6 deals in 12 mo
HHillhouse Investment11 companies · 4 deals in 12 mo
PPlus Capital11 companies · 4 deals in 12 mo
SS3 Ventures11 companies · 4 deals in 12 mo
BBain Capital Life Sciences11 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 16 rounds on Recent Funding that name PMV. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists PMV, which is a subset of its real portfolio. API: /api/v1/investors/pmv (get a free API key). More: the most active VC firms and new venture capital funds.